Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-craniotomy pain management with subcutaneous sumatriptan
ACTRN12618000793213Phase 3Not yet recruiting
- Sponsor
- Austin Hospital
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of sumatriptan in postoperative pain, sponsored by Austin Hospital. Primary endpoint: Post-craniotomy pain. Planned start Oct 2018; status: not yet recruiting.
02
Drugs
sumatriptan
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ACTRN12618000793213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618000793213.